Shares of PetMed Express, Inc. (NASDAQ:PETS) were down 5.8% during trading on Monday . The stock traded as low as $41.33 and last traded at $41.73, with a volume of 1,154,443 shares changing hands. The stock had previously closed at $44.29.

Several analysts recently commented on PETS shares. Craig Hallum downgraded shares of PetMed Express from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Zacks Investment Research upgraded shares of PetMed Express from a “hold” rating to a “strong-buy” rating and set a $38.00 price target for the company in a research report on Wednesday, May 10th. Noble Financial reiterated a “hold” rating on shares of PetMed Express in a research report on Wednesday, July 26th. Finally, Northcoast Research upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price target for the company in a research report on Monday, July 24th.

The company’s 50 day moving average is $44.44 and its 200-day moving average is $31.37. The firm has a market capitalization of $846.79 million, a PE ratio of 32.10 and a beta of 0.99.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, July 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. The company had revenue of $79.66 million for the quarter, compared to analysts’ expectations of $77.32 million. PetMed Express had a return on equity of 28.67% and a net margin of 10.34%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same period last year, the business posted $0.32 earnings per share. Analysts forecast that PetMed Express, Inc. will post $1.44 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, August 18th. Shareholders of record on Monday, August 7th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date was Thursday, August 3rd. PetMed Express’s payout ratio is 61.54%.

In other PetMed Express news, Director Robert C. Schweitzer sold 2,500 shares of the firm’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $49.18, for a total value of $122,950.00. Following the sale, the director now directly owns 88,834 shares in the company, valued at $4,368,856.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronald J. Korn sold 5,000 shares of the firm’s stock in a transaction on Friday, July 28th. The shares were sold at an average price of $48.18, for a total value of $240,900.00. Following the completion of the sale, the director now owns 67,333 shares in the company, valued at $3,244,103.94. The disclosure for this sale can be found here. Insiders sold 19,333 shares of company stock worth $949,730 over the last quarter. 4.00% of the stock is currently owned by company insiders.

Large investors have recently modified their holdings of the stock. Acadian Asset Management LLC bought a new stake in shares of PetMed Express during the second quarter worth $18,691,000. Oaktop Capital Management II L.P. bought a new stake in shares of PetMed Express during the second quarter worth $15,171,000. Vanguard Group Inc. boosted its stake in shares of PetMed Express by 21.0% in the second quarter. Vanguard Group Inc. now owns 1,300,725 shares of the company’s stock worth $52,810,000 after buying an additional 225,474 shares in the last quarter. Koch Industries Inc. bought a new stake in shares of PetMed Express during the second quarter worth $212,000. Finally, Renaissance Technologies LLC boosted its stake in shares of PetMed Express by 11.8% in the first quarter. Renaissance Technologies LLC now owns 1,786,315 shares of the company’s stock worth $35,976,000 after buying an additional 188,615 shares in the last quarter. Institutional investors and hedge funds own 79.12% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “PetMed Express, Inc. (PETS) Stock Price Down 5.8%” was first published by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/08/21/petmed-express-inc-pets-stock-price-down-5-8.html.

About PetMed Express

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.